Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

Bard, Frédérique, Cannon, Catherine, Barbour, Robin, Burke, Rae-Lyn, Games, Dora, Grajeda, Henry, Guido, Teresa, Hu, Kang +15 more·2000·Nature Medicine

DOI 10.1038/78682

Cited by (1,003)

Items 701–800 of 1,003

Disaggregation of Amyloid Plaque in Brain of Alzheimer’s Disease Transgenic Mice with Daily Subcutaneous Administration of a Tetravalent Bispecific Antibody That Targets the Transferrin Receptor and the Abeta Amyloid Peptide
Rachita K. Sumbria, Eric Ka‐Wai Hui, Jeff Zhiqiang Lu, Rubén J. Boado, William M. Pardridge · 2013 · Molecular Pharmaceutics
Pyroglutamate-Modified Amyloid Beta Peptides: Emerging Targets for Alzheimer´s Disease Immunotherapy
Roxanna Pérez-Garmendia, Goar Gevorkian · 2013 · Current Neuropharmacology
Current Insights into Molecular Mechanisms of Alzheimer Disease and Their Implications for Therapeutic Approaches
Bianca Van Broeck, Christine Van Broeckhoven, Samir Kumar‐Singh · 2007 · Neurodegenerative Diseases
Nonviral Aβ DNA vaccine therapy against Alzheimer’s disease: Long-term effects and safety
Yoshio Okura, Akira Miyakoshi, Kuniko Kohyama, Il-Kwon Park, Matthias Staufenbiel, Yoh Matsumoto · 2006 · Proceedings of the National Academy of Sciences
CD40 signaling and Alzheimer's disease pathogenesis
Terrence Town, Jun Tan, MICHAEL J. MULLAN · 2001 · Neurochemistry International
Alzheimer's disease with spastic paresis and cotton wool type plaques
Takeshi Tabira, De Hua Chui, Hiroshi Nakayama, Shigetoshi Kuroda, Makoto Shibuya · 2002 · Journal of Neuroscience Research
Superoxide Production at Phagosomal Cup/Phagosome through βI Protein Kinase C during FcγR-Mediated Phagocytosis in Microglia
Takehiko Ueyama, Michelle R. Lennartz, Yukiko Noda, Toshihiro Kobayashi, Yasuhito Shirai, Kyoko Rikitake, Tomoko Yamasaki, Shigeto Hayashi, Norio Sakai, Harumichi Seguchi et al. · 2004 · The Journal of Immunology
Characterization of murine immunoglobulin G antibodies against human amyloid-β1–42
Terrence Town, Jun Tan, Nicholas Sansone, Demian F. Obregon, Thomas Klein, MICHAEL J. MULLAN · 2001 · Neuroscience Letters
An anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1ΔE9 mice
Jeffrey L. Frost, Bin Liu, Jens‐Ulrich Rahfeld, Martin Kleinschmidt, Brian O’Nuallain, Kevin X. Le, Inge Lues, Barbara J. Caldarone, Stephan Schilling, Hans‐Ulrich Demuth et al. · 2015 · Neurobiology of Aging
Assessment of neuroprotection in the retina with DARC
Li Guo, Maria Francesca Cordeiro · 2008 · Progress in brain research
A fresh perspective from immunologists and vaccine researchers: Active vaccination strategies to prevent and reverse Alzheimer's disease
Michael G. Agadjanyan, Nikolai Petrovsky, Anahit Ghochikyan · 2015 · Alzheimer s & Dementia
Aβ Immunotherapy Protects Morphology and Survival of Adult-Born Neurons in Doubly Transgenic APP/PS1 Mice
Barbara Biscaro, Olle Lindvall, Christoph Höck, Christine T. Ekdahl, Roger M. Nitsch · 2009 · Journal of Neuroscience
How to Get from Here to There: Macrophage Recruitment in Alzheimers Disease
Kavon P. Rezai-Zadeh, David Gate, Genevíève Gowing, Terrence Town · 2011 · Current Alzheimer Research
Transcutaneous β-amyloid immunization reduces cerebral β-amyloid deposits without T cell infiltration and microhemorrhage
William V. Nikolic, Yun Bai, Demian F. Obregon, Huayan Hou, Takashi Mori, Jin Zeng, Jared C. Ehrhart, R. Douglas Shytle, Brian N. Giunta, David Morgan et al. · 2007 · Proceedings of the National Academy of Sciences
Aβ immunization and anti-Aβ antibodies: potential therapies for the prevention and treatment of Alzheimer’s disease
David M. Holtzman, Kelly R. Bales, Steven M. Paul, Ronald Bradley Demattos · 2002 · Advanced Drug Delivery Reviews
How the immune system shapes neurodegenerative diseases
Hannah D. Mason, Dorian B. McGavern · 2022 · Trends in Neurosciences
Activation of AMPK by GLP-1R agonists mitigates Alzheimer-related phenotypes in transgenic mice
Yun Zhang, Huaqiu Chen, Yijia Feng, Mingjing Liu, Zhi Lu, Bolang Hu, Lifen Chen, Yang Zhang, Jiawen Liu, Fang Cai et al. · 2025 · Nature Aging
Targeting β-Amyloid Pathology in Alzheimer's Disease with Aβ Immunotherapy
Roger M. Nitsch, Christoph Höck · 2008 · Neurotherapeutics
Modulation of inflammatory pathways by the immune cholinergic system
Eran Nizri‏, Talma Brenner · 2011 · Amino Acids
Memantine in the treatment of mild-to-moderate Alzheimer’s disease
Kelly M Cosman, Lisa L. Boyle, Anton P. Porsteinsson · 2007 · Expert Opinion on Pharmacotherapy
EFRH–Phage Immunization of Alzheimer's Disease Animal Model Improves Behavioral Performance in Morris Water Maze Trials
Vered Lavie, Maria Becker, Rachel Cohen-Kupiec, Iftach Yacoby, Rela Koppel, Manuela Wedenig, Birgit Hutter‐Paier, Beka Solomon · 2004 · Journal of Molecular Neuroscience
Neutralization of Soluble, Synaptotoxic Amyloid β Species by Antibodies Is Epitope Specific
Zago, Wagner, Buttini, Manuel, Comery, Thomas A., Nishioka, Christopher, Gardai, Shyra J., Seubert, Peter, Games, Dora, Bard, Frédérique, Schenk, Dale, Kinney, Gene G. · 2012 · The Journal of Neuroscience
Strategies, Development, and Pitfalls of Therapeutic Options for Alzheimer's Disease
C. Haas · 2012 · Journal of Alzheimer's Disease
Cells of monocyte/microglial lineage are involved in both microvessel amyloidosis and fibrillar plaque formation in APPsw tg mice
Jerzy Węgiel, Humi Imaki, Kuo-Chiang Wang, Jarek Wegiel, Richard Rubenstein · 2004 · Brain Research
Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer’s Disease
Yijun Xu, Ngan Pan Bennett Au, Chi Him Eddie Ma · 2022 · Frontiers in Aging Neuroscience
The Amyloid-Beta Clearance: From Molecular Targets to Glial and Neural Cells
Wenjun Cai, Tong Wu, Ning Chen · 2023 · Biomolecules
Autoantibodies in patients with Alzheimer's disease: pathogenetic role and potential use as biomarkers of disease progression
Tania Colasanti, Cristiana Barbati, Giuseppe M.C. Rosano, Walter Malorni, Elena Ortona · 2010 · Autoimmunity Reviews
Organoplatinum‐Substituted Polyoxometalate Inhibits β‐amyloid Aggregation for Alzheimer's Therapy
Jing Wei Zhao, Kexin Li, Kaiwei Wan, Tiedong Sun, Nannan Zheng, Fanjiao Zhu, Jichao Ma, Jia Jiao, Tianchan Li, Jinyuan Ni et al. · 2019 · Angewandte Chemie International Edition
Direct in Vivo Intracellular Selection of Conformation-sensitive Antibody Domains Targeting Alzheimer's Amyloid-β Oligomers
Giovanni Meli, Michela Visintin, Isabella Cannistraci, Antonino Cattaneo · 2009 · Journal of Molecular Biology
Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites
Atsushi Sasaki, Mikio Shoji, Yasuo Harigaya, Takeshi Kawarabayashi, Masaki Ikeda, Makoto Naito, Etsuro Matsubara, Koji Abe, Yoichi Nakazato · 2002 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
Overexpression of Macrophage Colony-stimulating Factor Receptor on Microglial Cells Induces an Inflammatory Response
Olivera M. Mitrasinovic, Grace V. Perez, Feifei Zhao, Yuen Ling Lee, Clara Poon, Greer M. Murphy · 2001 · Journal of Biological Chemistry
Vascular alterations in PDAPP mice after anti‐Aβ immunotherapy: Implications for amyloid‐related imaging abnormalities
Zago, Wagner, Schroeter, Sally, Guido, Teresa, Khan, Karen, Seubert, Peter, Yednock, Ted, Schenk, Dale, Gregg, Keith M., Games, Dora, Bard, Frédérique et al. · 2013 · Alzheimer's & Dementia
In vivo imaging of alpha-synuclein with antibody-based PET
Sahar Roshanbin, Mengfei Xiong, Greta Hultqvist, Linda Söderberg, Olof Zachrisson, Silvio R. Meier, Sara Ekmark‐Lewén, Joakim J. E. Bergström, Martin Ingelsson, Dag Sehlin et al. · 2022 · Neuropharmacology
Substrate ectodomain is critical for substrate preference and inhibition of γ-secretase
Satoru Funamoto, Toru Sasaki, Seiko Ishihara, Mika Nobuhara, Masaki Nakano, Miho Watanabe‐Takahashi, Takashi Saito, Nobuto Kakuda, Tomohiro Miyasaka, Kiyotaka Nishikawa et al. · 2013 · Nature Communications
Immunization Therapy for Alzheimer Disease: A Comprehensive Review of Active Immunization Strategies
Takeshi Tabira · 2010 · The Tohoku Journal of Experimental Medicine
Aβ Immunotherapy: Lessons Learned for Potential Treatment of Alzheimer’s Disease
Dale B. Schenk, Peter A. Seubert, Michael Grundman, Ron Black · 2005 · Neurodegenerative Diseases
What does complement do in Alzheimer’s disease? Old molecules with new insights
Yong Shen, Libang Yang, Rena Li · 2013 · Translational Neurodegeneration
The immune system, amyloid‐β peptide, and Alzheimer's disease
Marc E. Weksler, Gunnar K. Gouras, Norman R. Relkin, Paul Szabo · 2005 · Immunological Reviews
Stress proteins and glial functions: possible therapeutic targets for neurodegenerative disorders
Yoshihisa Kitamura, Yasuyuki Nomura · 2002 · Pharmacology & Therapeutics
Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches
Niyanta N. Kumar, Michelle E. Pizzo, Geetika Nehra, Brynna Wilken-Resman, Sam Boroumand, Robert G. Thorne · 2018 · Bioconjugate Chemistry
α‐Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives
Obada M. Alzghool, Guus A.M.S. van Dongen, Elsmarieke van de Giessen, Linda Jeanne Schoonmade, Wissam Beaino · 2022 · Movement Disorders
Antibody‐based approaches in Alzheimer’s research: safety, pharmacokinetics, metabolism, and analytical tools
Peter Lichtlen, M. Hasan Mohajeri · 2007 · Journal of Neurochemistry
Bapineuzumab: Anti-β-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer‘s Disease
Francesco Panza, Vincenza Frisardi, Bruno Pietro Imbimbo, Grazia D’Onofrio, Giuseppe Pietrarossa, Davide Seripa, Alberto Pilotto, Vincenzo Solfrizzi · 2010 · Immunotherapy
Developing therapeutic vaccines against Alzheimer’s disease
Thomas Wısnıewskı, Eleanor Drummond · 2015 · Expert Review of Vaccines
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients
Francesco Panza, Davide Seripa, Vincenzo Solfrizzi, Bruno Pietro Imbimbo, Madia Lozupone, Antonio Leo, Rodolfo Sardone, Gaetano Gagliardi, Lucia Lofano, Bianca C. Creanza et al. · 2016 · Expert Opinion on Emerging Drugs
Review: Neuropathology and behavioural features of transgenic murine models of Alzheimer's disease
Kamar E. Ameen‐Ali, Stephen B. Wharton, Julie E. Simpson, Paul Roy Heath, Paul S. Sharp, Jason Berwick · 2017 · Neuropathology and Applied Neurobiology
A case for a non‐transgenic animal model of Alzheimer's disease
Aline Stéphan, A. G. Phillips · 2005 · Genes Brain & Behavior
Fcγ Receptor I- and III-Mediated Macrophage Inflammatory Protein 1α Induction in Primary Human and Murine Microglia
Xianyuan Song, Scott Shapiro, David L. Goldman, Arturo Casadevall, Matthew D. Scharff, Sunhee C. Lee · 2002 · Infection and Immunity
Myeloid Cells in Alzheimer's Disease: Culprits, Victims or Innocent Bystanders?
Melanie Meyer‐Luehmann, Marco Prinz · 2015 · Trends in Neurosciences
Behind the curtain of tauopathy: a show of multiple players orchestrating tau toxicity
Yunpeng Huang, Zhihao Wu, Bing Zhou · 2015 · Cellular and Molecular Life Sciences
Microglial Amyloid- β 1-40 Phagocytosis Dysfunction Is Caused by High-Mobility Group Box Protein-1: Implications for the Pathological Progression of Alzheimer’s Disease
Kazuyuki Takata, Tetsuya Takada, Aina Ito, Mayo Asai, Manami Tawa, Yuki Saito, Eishi Ashihara, Hidekazu Tomimoto, Yoshihisa Kitamura, Shun Shimohama · 2012 · International Journal of Alzheimer s Disease
Tetrandrine suppresses amyloid-β-induced inflammatory cytokines by inhibiting NF-κB pathway in murine BV2 microglial cells
Fu Qian He, Bo Yun Qiu, Tianke Li, Qin Xie, De Jun Cui, Xiao Li Huang, Hua Tian Gan · 2011 · International Immunopharmacology
Antibody-based therapy in Alzheimer's disease
Refik Pul, Richard C. Dodel, Martin Stangel · 2011 · Expert Opinion on Biological Therapy
Don't forget astrocytes when targeting Alzheimer's disease
Jessica S. Sadick, Shane Antony Liddelow · 2019 · British Journal of Pharmacology
Novel roles for Nogo receptor in inflammation and disease
Samuel David, Elizabeth J. Fry, Rubén López‐Vales · 2008 · Trends in Neurosciences
Pharmacogenomics of neurodegenerative diseases
Davide Maimone, Roberto Dominici, Luigi M. E. Grimaldi · 2001 · European Journal of Pharmacology
Transferrin receptor-targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA.
Pizzo, Michelle E., Plowey, Edward D., Khoury, Nathalie, Kwan, Wanda, Abettan, Jordan, DeVos, Sarah L., Discenza, Claire B., Earr, Timothy, Joy, David, Lye-Barthel, Ming et al. · 2025 · Science
Review: Experimental manipulations of microglia in mouse models of <scp>A</scp>lzheimer's pathology: activation reduces amyloid but hastens tau pathology
Lee, D. C., Rizer, J., Hunt, J. B., Selenica, M.‐L. B., Gordon, M. N., Morgan, D. · 2013 · Neuropathology and Applied Neurobiology
Alzheimer disease neuropathology in a patient previously treated with aducanumab
Edward D. Plowey, Thierry Bussière, Raj Rajagovindan, Jennifer Sebalusky, Stefan Hamann, Christian von Hehn, Carmen Castrillo‐Viguera, Alfred W. Sandrock, Samantha Budd Haeberlein, Christopher H. van Dyck et al. · 2022 · Acta Neuropathologica
Lessons Learned from Approval of Aducanumab for Alzheimer's Disease
Judith L. Heidebrink, Henry Lauris Paulson · 2024 · Annual Review of Medicine
Pharmacotherapeutic targets in Alzheimer's disease
Yif'at Biran, Colin Louis Masters, Kevin Jeffrey Barnham, Ashley Ian Bush, Paul Anthony Adlard · 2008 · Journal of Cellular and Molecular Medicine
Plasma amyloid-β oligomers level is a biomarker for Alzheimer’s disease diagnosis
L. Zhou, Koon Ho Chan, Leung‐Wing Chu, Jason Kwan, You‐Qiang Song, L.H. Chen, Philip Wing‐Lok Ho, Olivia Cheng, Jessica Wing-Man Ho, Karen S.L. Lam · 2012 · Biochemical and Biophysical Research Communications
Pharmacokinetics, biodistribution and brain retention of a bispecific antibody-based PET radioligand for imaging of amyloid-β
Dag Sehlin, Xiaotian T. Fang, Silvio R. Meier, Malin Jansson, Stina Syvänen · 2017 · Scientific Reports
Effects of Lipophilicity on the Affinity and Nonspecific Binding of Iodinated Benzothiazole Derivatives
Yanming Wang, Chester A. Mathis, Guo-Feng Huang, Manik L. Debnath, Daniel P. Holt, Li Shao, William Edward Klunk · 2003 · Journal of Molecular Neuroscience
Aberrant expressions of pathogenic phenotype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw
Hwang, Dae Y., Cho, Jung S., Lee, Su H., Chae, Kab R., Lim, Hwa J., Min, Sea H., Seo, Su J., Song, Youn S., Song, Chi W., Paik, Sang G. et al. · 2004 · Experimental Neurology
A nasal proteosome adjuvant activates microglia and prevents amyloid deposition
Dan Frenkel, Lindsay L. Puckett, Sanja Petrovic, Weiming Xia, Guiquan Chen, Jose Vega, Adi Dembinsky‐Vaknin, Jie Shen, Martin Plante, David S. Burt et al. · 2008 · Annals of Neurology
Antibody-Mediated Clearance of Amyloid-β Peptide from Cerebral Amyloid Angiopathy Revealed by QuantitativeIn VivoImaging
Claudia M. Prada, Mónica Garcı́a-Alloza, Rebecca A. Betensky, Sandy Zhang-Nunes, Steven Mark Greenberg, Brian J. Bacskai, Matthew P. Frosch · 2007 · Journal of Neuroscience
Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer’s disease-related symptoms and pathology
Wenlin Hao, Yang Liu, Shirong Liu, Silke Walter, Marcus O.W. Grimm, Amanda J. Kiliaan, Botond Penke, Tobias Hartmann, Claudia E. Rübe, Michael Dieter Menger et al. · 2010 · Brain
Vaccination against β-Amyloid as a Strategy for the Prevention of Alzheimer’s Disease
Mantile, Francesca, Prisco, Antonella · 2020 · Biology
DNA vaccination against mutant huntingtin ameliorates the HDR6/2 diabetic phenotype
Todd W. Miller, Thomas L. Shirley, William J. Wolfgang, Xiaowei Kang, Anne C. Messer · 2003 · Molecular Therapy
Importance of IgG2c isotype in the immune response to β-amyloid in amyloid precursor protein/transgenic mice
Irina Petrushina, Mike Tran, Nadya Sadzikava, Anahit Ghochikyan, Vitaly Vasilevko, Michael G. Agadjanyan, David H. Cribbs · 2003 · Neuroscience Letters
Modeling Alzheimer's disease immune therapy mechanisms: Interactions of human postmortem microglia with antibody‐opsonized amyloid beta peptide
Lih‐Fen Lue, Douglas G. Walker · 2002 · Journal of Neuroscience Research
Recent advancement in therapeutic strategies for Alzheimer’s disease: Insights from clinical trials
Tanzeel Khan, Rashid Waseem, Mohammad Shahid, Jaoud Ansari, Ishfaq Ahmad Ahanger, Md. Imtaiyaz Hassan, Asimul Islam · 2023 · Ageing Research Reviews
Increased Levels of Antigen-Bound β-Amyloid Autoantibodies in Serum and Cerebrospinal Fluid of Alzheimer’s Disease Patients
Madalina Maftei, Franka Thurm, Cathrin Schnack, Hayrettin Tumani, Markus Otto, Thomas R. Elbert, Iris‐Tatjana Kolassa, Michael Przybylski, Marilena Manea, Christine A. F. Von Arnim · 2013 · PLoS ONE
Accelerated Phagocytosis of Amyloid-β by Mouse and Human Microglia Overexpressing the Macrophage Colony-stimulating Factor Receptor
Olivera M. Mitrasinovic, Greer M. Murphy · 2002 · Journal of Biological Chemistry
Neuroinflammation in Alzheimer's disease: protector or promoter?
Norbert Žilka, M Ferencĭk, I Hulín · 2006 · Bratislavské lekárske listy/Bratislava medical journal
Immunotherapy Targeting α-Synuclein, with Relevance for Future Treatment of Parkinson‘s Disease and Other Lewy Body Disorders
Veronica Lindström, Elisabet Ihse, Therese Fagerqvist, Joakim J. E. Bergström, Eva K. L. Nordström, Christer Möller, Lars Lannfelt, Martin Ingelsson · 2014 · Immunotherapy
Sex Differences between Neuronal Loss and the Early Onset of Amyloid Deposits and Behavioral Consequences in 5xFAD Transgenic Mouse as a Model for Alzheimer’s Disease
Chi Him Poon, San Tung Nicholas Wong, Jaydeep Roy, Yingyi Wang, Hui Wang Hujo Chan, Harry W.M. Steinbusch, Arjan Blokland, Yasin Temel, Luca Aquili, Lee Wei Lim · 2023 · Cells
Immunotherapy as a therapeutic treatment for neurodegenerative disorders
Anthony Robert White, Simon H Hawke · 2003 · Journal of Neurochemistry
Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer’s disease
Malú G. Tansey, McAlpine · 2008 · Journal of Inflammation Research
Dendrimeric Aβ1–15 is an effective immunogen in wildtype and APP-tg mice
Timothy J. Seabrook, Katelyn Thomas, Liying Jiang, Jeanne K. Bloom, Edward Spooner, Marcel Maier, Gal Bitan, Cynthia Ann Lemere · 2006 · Neurobiology of Aging
Amelioration of amyloid load by anti-Aβ single-chain antibody in Alzheimer mouse model
Ken‐ichiro Fukuchi, Mary Ann Accavitti-Loper, Hong Duck Kim, Kazuki Tahara, Yunpeng Cao, Terry L. Lewis, Robert C. Caughey, Helen Kim, Robert Lalonde · 2006 · Biochemical and Biophysical Research Communications
Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease
Hong‐Duck Kim, Jing-Ji Jin, J. Adam Maxwell, Ken-ichiro Fukuchi · 2007 · Immunology Letters
Do age-associated changes in ‘physiologic’ autoantibodies contribute to infection, atherosclerosis, and Alzheimer's disease?
Marc E. Weksler, Michèle Goodhardt · 2002 · Experimental Gerontology
Prevention of Alzheimer's Disease-associated Aβ Aggregation by Rationally Designed Nonpeptidic β-Sheet Ligands
Petra Rzepecki, Luitgard Nagel‐Steger, Sophie Feuerstein, Uwe Linne, Oliver Molt, Reza Zadmard, Katja Aschermann, Markus Wehner, Thomas H. Schrader, Detlev Riesner · 2004 · Journal of Biological Chemistry
Immunological and Anti-Chaperone Therapeutic Approaches for Alzheimer Disease
Thomas Wısnıewskı, Blas Frangione · 2006 · Brain Pathology
Reversal of amyloid β toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid β antibody
Neelima B. Chauhan, George J. Siegel · 2002 · Journal of Neuroscience Research
Generation and characterization of the humoral immune response to DNA immunization with a chimeric β‐amyloid‐interleukin‐4 minigene
Anahit Ghochikyan, Vitaly Vasilevko, Irina Petrushina, Nina Movsesyan, Davit Babikyan, Wenqiang Tian, Nadya Sadzikava, Ted M. Ross, Elizabeth Head, David H. Cribbs et al. · 2003 · European Journal of Immunology
Conformation-specific antibodies to target amyloid β oligomers and their application to immunotherapy for Alzheimer’s disease
Kazuma Murakami · 2014 · Bioscience Biotechnology and Biochemistry
Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice
Alexandra J. Mably, Wen Liu, Jessica M. Mc Donald, Jean‐Cosme Dodart, Frédérique Bard, Cynthia Ann Lemere, Brian O’Nuallain, Dominic M. Walsh · 2015 · Neurobiology of Disease
Valproic acid enhances microglial phagocytosis of amyloid-β1–42
A.M. Smith, Hannah M. Gibbons, Mike Dragunow · 2010 · Neuroscience
Minocycline reduces engraftment and activation of bone marrow‐derived cells but sustains their phagocytic activity in a mouse model of Alzheimer's disease
Tarja Malm, Johanna M. Magga, Georges Ful Kuh, Tero Vatanen, Milla Koistinaho, Jari Koıstınaho · 2008 · Glia
Beta-amyloid auto-antibodies are reduced in Alzheimer's disease
Bao‐Xi Qu, Yunhua Gong, Carol B. Moore, Min Fu, Dwight C. German, Ling-Yu E. Chang, Roger N. Rosenberg, Ramon R. Diaz-Arrastia · 2014 · Journal of Neuroimmunology
Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease
Kazuhiko Matsuo, Hideaki Okamoto, Yasuaki Kawai, Ying‐Shu Quan, Fumio Kamiyama, Sachiko Hirobe, Naoki Okada, Shinsaku Nakagawa · 2013 · Journal of Neuroimmunology
Efficacy and safety studies of gantenerumab in patients with Alzheimer’s disease
Francesco Panza, Vincenzo Solfrizzi, Bruno Pietro Imbimbo, Michele Giannini, Andrea Santamato, Davide Seripa, Giancarlo Logroscino · 2014 · Expert Review of Neurotherapeutics
A bispecific Tribody PET radioligand for visualization of amyloid-beta protofibrils – a new concept for neuroimaging
Stina Syvänen, Xiaotian T. Fang, Greta Hultqvist, Silvio R. Meier, Lars Lannfelt, Dag Sehlin · 2017 · NeuroImage
Importance of GPCR-Mediated Microglial Activation in Alzheimer’s Disease
Md. Ezazul Haque, In‐Su Kim, Md. Jakaria, Mahbuba Akther, Dong‐Kug Choi · 2018 · Frontiers in Cellular Neuroscience
Learning from the Past: A Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer’s Disease
Kelly Ceyzériat, Thomas Zilli, P. Millet, Giovanni Battista Frisoni, Valentina Garibotto, Benjamin B. Tournier · 2020 · Current Alzheimer Research
Decrease in pathology and progression of scrapie after immunisation with synthetic prion protein peptides in hamsters
Giuliana Magri, Mario Clerici, Paola Dall’Ara, Mara Biasin, Maria Caramelli, Cristina Casalone, Maria Laura Giannino, Renato Longhi, Luca Piacentini, Silvia Della Bella et al. · 2005 · Vaccine
Mechanisms of Aβ Plaque Clearance following Passive Aβ Immunization
David Morgan · 2005 · Neurodegenerative Diseases